Hubei Jumpcan Pharmaceutical Co Ltd (600566) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Hubei Jumpcan Pharmaceutical Co Ltd (600566) has a cash flow conversion efficiency ratio of -0.018x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-243.75 Million ≈ $-35.67 Million USD) by net assets (CN¥13.86 Billion ≈ $2.03 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 600566 company net worth for the company's overall valuation and market capitalisation.
Hubei Jumpcan Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2000–2025)
This chart illustrates how Hubei Jumpcan Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Hubei Jumpcan Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hubei Jumpcan Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore Hubei Jumpcan Pharmaceutical Co Ltd cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
National Energy Services Reunited Corp Ordinary Shares
NASDAQ:NESR
|
0.167x |
|
Seabridge Gold Inc.
TO:SEA
|
-0.002x |
|
Life360, Inc. Common Stock
NASDAQ:LIF
|
0.032x |
|
The New India Assurance Company Limited
NSE:NIACL
|
-0.141x |
|
Jiangsu Changshu Rural Commercial Bank Co Ltd
SHG:601128
|
-0.165x |
|
Shenzhen Kstar Science & Technology Co Ltd
SHE:002518
|
0.074x |
|
Multistrada Arah Sarana Tbk
JK:MASA
|
0.131x |
|
Sinomach Heavy Equipment Group Co Ltd
SHG:601399
|
-0.020x |
Annual Cash Flow Conversion Efficiency for Hubei Jumpcan Pharmaceutical Co Ltd (2000–2025)
The table below shows the annual cash flow conversion efficiency of Hubei Jumpcan Pharmaceutical Co Ltd from 2000 to 2025. View Hubei Jumpcan Pharmaceutical Co Ltd stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥14.63 Billion ≈ $2.14 Billion |
CN¥1.20 Billion ≈ $175.35 Million |
0.082x | -44.59% |
| 2024-12-31 | CN¥14.73 Billion ≈ $2.15 Billion |
CN¥2.18 Billion ≈ $318.48 Million |
0.148x | -42.96% |
| 2023-12-31 | CN¥13.37 Billion ≈ $1.96 Billion |
CN¥3.46 Billion ≈ $506.89 Million |
0.259x | +12.24% |
| 2022-12-31 | CN¥11.35 Billion ≈ $1.66 Billion |
CN¥2.62 Billion ≈ $383.51 Million |
0.231x | +11.28% |
| 2021-12-31 | CN¥9.13 Billion ≈ $1.34 Billion |
CN¥1.89 Billion ≈ $277.20 Million |
0.207x | -9.61% |
| 2020-12-31 | CN¥7.76 Billion ≈ $1.14 Billion |
CN¥1.78 Billion ≈ $260.72 Million |
0.230x | -34.77% |
| 2019-12-31 | CN¥6.10 Billion ≈ $893.27 Million |
CN¥2.15 Billion ≈ $314.27 Million |
0.352x | +12.35% |
| 2018-12-31 | CN¥5.46 Billion ≈ $798.65 Million |
CN¥1.71 Billion ≈ $250.10 Million |
0.313x | +15.96% |
| 2017-12-31 | CN¥4.40 Billion ≈ $644.12 Million |
CN¥1.19 Billion ≈ $173.95 Million |
0.270x | +9.06% |
| 2016-12-31 | CN¥3.69 Billion ≈ $539.60 Million |
CN¥913.10 Million ≈ $133.61 Million |
0.248x | +4.07% |
| 2015-12-31 | CN¥2.71 Billion ≈ $396.97 Million |
CN¥645.48 Million ≈ $94.45 Million |
0.238x | -11.41% |
| 2014-12-31 | CN¥2.29 Billion ≈ $335.68 Million |
CN¥616.11 Million ≈ $90.16 Million |
0.269x | +7.78% |
| 2013-12-31 | CN¥1.15 Billion ≈ $168.63 Million |
CN¥287.16 Million ≈ $42.02 Million |
0.249x | +352.79% |
| 2012-12-31 | CN¥490.80 Million ≈ $71.82 Million |
CN¥27.01 Million ≈ $3.95 Million |
0.055x | +6950.17% |
| 2011-12-31 | CN¥526.82 Million ≈ $77.09 Million |
CN¥411.24K ≈ $60.18K |
0.001x | -99.21% |
| 2010-12-31 | CN¥520.27 Million ≈ $76.13 Million |
CN¥51.13 Million ≈ $7.48 Million |
0.098x | +924.94% |
| 2009-12-31 | CN¥512.85 Million ≈ $75.05 Million |
CN¥4.92 Million ≈ $719.55K |
0.010x | -78.95% |
| 2008-12-31 | CN¥506.18 Million ≈ $74.07 Million |
CN¥23.05 Million ≈ $3.37 Million |
0.046x | -38.13% |
| 2007-12-31 | CN¥498.83 Million ≈ $72.99 Million |
CN¥36.72 Million ≈ $5.37 Million |
0.074x | +743.02% |
| 2006-12-31 | CN¥485.82 Million ≈ $71.09 Million |
CN¥4.24 Million ≈ $620.77K |
0.009x | -93.38% |
| 2005-12-31 | CN¥480.25 Million ≈ $70.28 Million |
CN¥63.38 Million ≈ $9.27 Million |
0.132x | +265.74% |
| 2004-12-31 | CN¥473.92 Million ≈ $69.35 Million |
CN¥-37.74 Million ≈ $-5.52 Million |
-0.080x | -1755.48% |
| 2003-12-31 | CN¥466.47 Million ≈ $68.26 Million |
CN¥2.24 Million ≈ $328.32K |
0.005x | -89.96% |
| 2002-12-31 | CN¥459.05 Million ≈ $67.17 Million |
CN¥22.00 Million ≈ $3.22 Million |
0.048x | +190.19% |
| 2001-12-31 | CN¥449.57 Million ≈ $65.79 Million |
CN¥7.43 Million ≈ $1.09 Million |
0.017x | -90.25% |
| 2000-12-31 | CN¥140.01 Million ≈ $20.49 Million |
CN¥23.73 Million ≈ $3.47 Million |
0.169x | -- |
About Hubei Jumpcan Pharmaceutical Co Ltd
Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of medicines in China. The company offers drugs in the fields of pediatrics, respiratory system, digestive system, and gynecology. It is also involved in daily chemical product sales; and wholesale and retail pharmaceuticals. The company is headquartered in Taixing, China.